Belite Bio, Inc (BLTE) released Loss for its fourth quarter that increased from the same period last year and missed the Street estimates.
The company's earnings totaled -$10.1 million, or -$0.32 per share. This compares with -$7 million, or -$0.25 per share, last year.
Analysts on average had expected the company to earn -$0.31 per share. Analysts' estimates typically exclude special items.
Belite Bio, Inc earnings at a glance (GAAP) :
-Earnings: -$10.1 Mln. vs. -$7 Mln. last year.
-EPS: -$0.32 vs. -$0.25 last year.
For comments and feedback: editorial@rttnews.com